Q45878 (Q45878_CLOBO) Clostridium botulinum
Non-toxin haemagglutinin HA17 UniProtKBAFDB90v4InterProInteractive Modelling
146 aa; Sequence (Fasta) ;
3 identical sequences: Clostridium botulinum: A0A3F2ZS81, A5HZZ5; Clostridium botulinum CFSAN001627: M1ZNV3
It is possible new templates exist for this target since these models were created.
Available Structures
9 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Apo HA17-HA33 |
Heteromer Q45871; | |||||
| Assess | ||||||
| Crystal structure of HA17-HA33-IPT |
Heteromer Q45871; | 2×IPT; | ||||
| Assess | ||||||
| HA17-HA33-LacNac |
Heteromer Q45871; | 2×NDG; | ||||
| Assess | ||||||
| HA17-HA33-Lac |
Heteromer Q45871; | 2×BGC; | ||||
| Assess | ||||||
| HA17-HA33-Gal |
Heteromer Q45871; | 2×GAL; | ||||
| Assess | ||||||
| Crystal structure of HA17-HA33-Lactulose |
Heteromer Q45871; | 2×FRU; | ||||
| Assess | ||||||
| Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex |
Heteromer A5HZZ4; A5HZZ5; A5HZZ6; P09803; | 3×CA; | ||||
| Assess | ||||||
| HA70(D3)-HA17 |
Heteromer Q8KHU9; | |||||
| Assess | ||||||
| HA70(D3)-HA17-HA33 |
Heteromer Q45871; Q8KHU9; | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4qd2.2.B | monomer | 0.90 | 100.00 | |||
| Assess | ||||||
| 1ybi.2.A | monomer | 0.51 | 26.23 | |||
| Assess | ||||||